| Submit your comments on this article |
| Science & Technology |
| Israel isolates monoclonal anti-coronavirus antibody |
| 2020-05-05 |
| [YNet] - Israel has isolated a key coronavirus antibody at its main biological research laboratory, the defence minister said on Monday, calling the step a "significant breakthrough" toward a possible treatment for the COVID-19 pandemic. The "monoclonal neutralizing antibody" developed at the Israel Institute for Biological Research (IIBR) "can neutralize it (the disease-causing coronavirus) inside carriers' bodies," Defense Minister Naftali Bennett said in a statement. ...It quoted IIBR Director Shmuel Shapira as saying that the antibody formula was being patented, after which an international manufacturer would be sought to mass-produce it. Antibodies in such samples - immune-system proteins that are residues of successfully overcoming the coronavirus - are widely seen as a key to developing a possible cure. The antibody reported as having been isolated at the IIBR is monoclonal, meaning it was derived from a single recovered cell and is thus potentially of more potent value in yielding a treatment. Elsewhere, there have been coronavirus treatments developed from antibodies that are polyclonal, or derived from two or more cells of different ancestry, the magazine Science Direct reported in its May issue. |
| Posted by:g(r)omgoru |
| #3 ^ It's never not-good |
| Posted by: Frank G 2020-05-05 10:24 |
| #2 Good news, indeed. Wait. An anti-virus anti-body? Is that double-plus good? |
| Posted by: Bobby 2020-05-05 10:14 |
| #1 Very good news. |
| Posted by: Skidmark 2020-05-05 09:44 |